Tag Archives: Clinical Trials

PCORI Launches Clinical Research Network to Support Trials, Outcomes Research

By Jill Wechsler | Published: April 30, 2013
The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER),  the program also has potential to support development of new drugs and devices, explained PCORI executive director Joe [...]
Posted in FDA, healthcare | Also tagged , , , , , , , , , , , , , | Leave a comment

Crowd Sourcing: The Time Has Come

By Guest Blogger | Published: January 16, 2013
By Marylyn Donahue. Crowd sourcing is hardly new, not even for pharma. Pfizer launched the first ever clinical trial to recruit and communicate with patients entirely via the Internet in 2011. Although it did shut down earlier last year due to lack of participants. But that certainly doesn’t mean crowd sourcing (use of web-based technologies to recruit [...]
Posted in Strategy, Technology | Also tagged , , , , , | Leave a comment

Thinking of Phase IV Trials? Europe Might See Things Differently…

By Guest Blogger | Published: December 3, 2012
By Peter O’ Donnell. With the shadow cast by Mediator across Europe now receding to a focus on the French law courts, the European Union (EU) said in late November that its pharmacovigilance arrangements offer “one of the most advanced and comprehensive systems in the world”. Certainly the EU’s legislative framework has been significantly boosted over [...]
Posted in Europe, Global, Guest Blog, R&D | Also tagged , , , | Leave a comment

Clinical Trials Caught in Fallout of EC Health Minister Departure

By Guest Blogger | Published: November 12, 2012
The abrupt departure of Europe’s health commissioner continues to resonate across the European Union – and to leave plans for new clinical trials legislation without a patron, writes Peter O’ Donnell of Applied Clinical Trials. John Dalli, the former Maltese finance minister, was forced out of his job as Europe’s health supremo in mid-October, over suggestions [...]
Posted in Europe, Guest Blog, R&D | Also tagged , , | Leave a comment

Adaptive Trial Design and Combo Drugs Needed in Alzheimer’s

By Ben Comer | Published: October 17, 2012
FDA’s head of neurology products told industry execs at the Prix Galien Forum that the agency is open to alternative clinical trial designs in Alzheimer’s disease, and would like to see more combination products in clinical testing.
Posted in Agency Insight, FDA, R&D, Regulatory | Also tagged , | Leave a comment